GT Biopharma (GTBP) Intangibles (2010 - 2014)
GT Biopharma (GTBP) posted quarterly Intangibles of $21000.0 for Q1 2014, down 12.5% year-over-year from $24000.0 in Q1 2013, and down 4.55% quarter-over-quarter from $22000.0 in Q4 2013.
GT Biopharma (GTBP) Intangibles (2010 - 2014) Analysis & Trends
GT Biopharma (GTBP) has reported Intangibles for 5 consecutive years, with $21000.0 the latest figure, recorded in Q1 2014.
- In Q1 2014, Intangibles fell 12.5% year-over-year to $21000.0; the TTM figure through Mar 2014 stood at $21000.0 (down 12.5% YoY), while the FY2013 annual figure was $22000.0, down 8.33% from the prior year.
- Intangibles fell to $21000.0 in Q1 2014 per GTBP's latest filing, from $22000.0 in the prior quarter.
- Across five years, Intangibles topped out at $48000.0 in Q4 2010 and bottomed at -$13000.0 in Q4 2011.
- Historically, Intangibles has averaged $21909.1 across 5 years, with a median of $22000.0 in 2012.
- Annual changes were most pronounced in 2011 — Intangibles slumped 127.08% — and 2012, when it jumped 284.62%.
- GT Biopharma's Intangibles stood at $48000.0 in 2010, then tumbled by 127.08% to -$13000.0 in 2011, then surged by 284.62% to $24000.0 in 2012, then fell by 8.33% to $22000.0 in 2013, then decreased by 4.55% to $21000.0 in 2014.
- Business Quant data shows GTBP's Intangibles at $21000.0 in Q1 2014, $22000.0 in Q4 2013, and $24000.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GT Biopharma | 8.64 Mn | 8.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 21,000.00 |
| Dec 31, 2013 | 22,000.00 |
| Mar 31, 2013 | 24,000.00 |
| Dec 31, 2012 | 24,000.00 |
| Sep 30, 2012 | 15,000.00 |
| Jun 30, 2012 | 16,000.00 |
| Mar 31, 2012 | 22,000.00 |
| Dec 31, 2011 | -13,000.00 |
| Sep 30, 2011 | 28,000.00 |
| Jun 30, 2011 | 34,000.00 |
| Dec 31, 2010 | 48,000.00 |